Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
Hydrea (Hydroxyurea)
| Hydroxyurea (Generic) Hydroxyurea (Hydroxycarbamide) | ||||||
|
Shipped from Canada | ||||||
| | ||||||
| Select product strength & quantity:
Who is the product for? YouOtherAdd Family Member/PetYou must be logged in to add additional members to the order. Don't have an account? or Add Family Member/PetSign inTo continue, please enter your email address and password that you use for your account. | ||||||
General Medication Fact Sheet for Hydrea
| Field | Information |
|---|---|
| Medication Name | Hydrea |
| Generic Name | Hydroxyurea |
| Boxed/Label Warning | May cause myelosuppression (decreased blood cell counts), which can lead to serious infections or bleeding. Secondary malignancies, including leukemia, have been reported. Embryo-fetal toxicity. |
| Purpose | Used to treat certain types of cancer (e.g., chronic myeloid leukemia, squamous cell carcinomas) and sickle cell anemia. |
| Mechanism of Action | Inhibits DNA synthesis by interfering with ribonucleotide reductase, an enzyme essential for DNA replication. In sickle cell anemia, it increases fetal hemoglobin (HbF) production, which reduces sickling of red blood cells. |
| Dosage Forms | Capsules |
| Available Strengths | 200 mg, 300 mg, 400 mg, 500 mg |
| Dosage Frequency | Varies depending on the condition being treated, typically once daily. |
| Common Side Effects | Nausea, vomiting, diarrhea, constipation, loss of appetite, mucositis (inflammation of the mouth and digestive tract), skin rash, hyperpigmentation, nail changes. |
| Serious Side Effects | Myelosuppression (anemia, leukopenia, thrombocytopenia), increased risk of infection, secondary malignancies (leukemia), skin cancer, pulmonary fibrosis, hepatotoxicity, peripheral neuropathy. |
| Drug Interactions | Didanosine, stavudine, other myelosuppressive agents (e.g., clozapine, azathioprine), live vaccines. |
| Important Notes | Monitor blood counts regularly. Use effective contraception during treatment and for a period after treatment. Avoid direct sun exposure. Stay hydrated. |
| Storage | Store at room temperature away from moisture and light. Keep out of reach of children. |
| Missed Dose | Take as soon as you remember unless it’s almost time for your next dose. Do not double the dose. Contact your doctor. |
| Alternatives | For sickle cell anemia: Endari (L-glutamine), Oxbryta (voxelotor), Adakveo (crizanlizumab). For cancer treatment, alternatives depend on the specific type of cancer. |
Hydrea Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Endari (L-glutamine) | Reduces oxidative stress in sickle cell anemia. | Indicated for reducing acute complications of sickle cell disease. |
| Oxbryta (voxelotor) | Inhibits hemoglobin polymerization in sickle cell disease. | Reduces red blood cell sickling. |
| Adakveo (crizanlizumab) | Binds to P-selectin to block interactions with other cells. | Reduces the frequency of vaso-occlusive crises in sickle cell disease. |
| Droxia (hydroxyurea) | Inhibits DNA synthesis, increases fetal hemoglobin. | Another brand name for hydroxyurea. |
Hydrea Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | Myelosuppression (decreased blood cell counts) |
| Vomiting | Increased risk of infection |
| Diarrhea | Secondary malignancies (leukemia, skin cancer) |
| Constipation | Pulmonary fibrosis |
| Loss of appetite | Hepatotoxicity (liver damage) |
| Skin rash | Peripheral neuropathy |
Hydrea Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Chronic Myeloid Leukemia (CML) | 20-30 mg/kg daily | Individualized based on blood counts and response | Adjust dose to maintain acceptable blood counts. |
| Sickle Cell Anemia | 15 mg/kg daily | Increase by 5 mg/kg every 12 weeks as tolerated, up to a maximum of 35 mg/kg daily | Monitor blood counts every two weeks during dose escalation, then every 8-12 weeks once stable. |
| Squamous Cell Carcinoma | 80 mg/kg every third day (with radiation) | As above, adjusted based on blood counts | Give with concurrent radiation therapy. |
Hydrea Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $10 |
| Without Insurance (U.S.) | $200 |
| From CPS | $81 |
